MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0107582
Gallium Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹50.81 Lakh
▲ 8% YoY
Net profit · FY 2025
₹8,900
Net margin 0.2%
EBITDA · FY 2025
₹21,778
EBITDA margin 0.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Gallium Pharmaceuticals Private Limited
Data last updated:
Gallium Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC301176. Its GSTIN is 27AAHCG0535G1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Bhagwat Natthuji and Nitin Natthuji Bhagwat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 Nandanvan Layout, Nagpur, Maharashtra, India – 440009.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.81 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹8,900 (net margin 0.2%) and EBITDA of ₹21,778 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
Gallium Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0107582). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website galliumpharmaceuticals.co.in.
Company details
CIN U24304MH2017PTC301176
Registration Number 301176
Incorporation Date 26 October 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0107582
Recognitions & Rankings of Gallium Pharmaceuticals
Contact details
Gallium Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is galliumpharmaceuticals.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address62 Nandanvan Layout, Nagpur, Maharashtra, India – 440009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gallium Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Gallium Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Gallium Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Gallium Pharmaceuticals Private Limited, buy the company report.
Financials of Gallium Pharmaceuticals Private Limited
FY 2025 filings availableGallium Pharmaceuticals Private Limited reported revenue of ₹50.81 Lakh (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹50.81 Lakh ▲ 8%
Net profit · FY 2025
₹8,900 margin 0.2%
EBITDA · FY 2025
₹21,778 margin 0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 3%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 32%
5 years · compounded
▼ 22%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 8% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,778 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,900 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gallium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gallium Pharmaceuticals Private Limited
Gallium Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Bhagwat Natthuji Also directs: Ozar Care Exim Private Limited | Director | 19 Apr 2018 | 8 Years 6 Months | Current |
| Nitin Natthuji Bhagwat Also directs: Nabnak Overseas LLP, Ozar Care Exim Private Limited | Director | 26 Oct 2017 | 8 Years 11 Months | Current |
Auditor
Gallium Pharmaceuticals Private Limited is audited by VIKAS MANGLANI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS MANGLANI & CO | FY 2021 | 134775W |
Shareholding
The shareholding of Gallium Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Gallium Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gallium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gallium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gallium Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG0535G1ZT | Maharashtra | Active | 26 Feb 2018 |
To see the full GST registrations and return filing status of Gallium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gallium Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Sachin Bhagwat Natthuji ceased to be Additional Director on 31 Dec 2018.
AGM
Gallium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gallium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Sachin Bhagwat Natthuji ceased to be Additional Director.
Ceased
Hitesh Gaurishankar Walode ceased to be Director.
Appointed
Sachin Bhagwat Natthuji was appointed as Director.
Appointed
Nitin Natthuji Bhagwat was appointed as Director.
Incorporation
26 Oct 2017
Gallium Pharmaceuticals Private Limited was registered on 26 Oct 2017 with Roc Mumbai & aged 8 years 11 months as per MCA records.
Frequently asked questions
Gallium Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U24304MH2017PTC301176.
Gallium Pharmaceuticals has 2 current directors:
- Sachin Bhagwat Natthuji - Director
- Nitin Natthuji Bhagwat - Director
The latest financial statements of Gallium Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Gallium Pharmaceuticals is 27AAHCG0535G1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gallium Pharmaceuticals is U24304MH2017PTC301176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gallium Pharmaceuticals was incorporated on 26 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Sachin Bhagwat Natthuji ceased to be Additional Director on 31 Dec 2018. Hitesh Gaurishankar Walode ceased to be Director on 19 Apr 2018. Sachin Bhagwat Natthuji was appointed as Director on 19 Apr 2018. Gallium Pharmaceuticals has 4 board changes on record in total.
Yes, Gallium Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0107582).
Gallium Pharmaceuticals can be reached through the website galliumpharmaceuticals.co.in. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Gallium Pharmaceuticals is at 62 Nandanvan Layout, Nagpur, Maharashtra, India – 440009.